AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Rabies Virus
7 registrations across 3 African markets— 7 active
Markets with Rabies Virus
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Raksharab Rabies vaccine Solution for Injection | 🇿🇲Zambia | Indian Immunologicals Limited (A wholly owned subsidiary of the NDDB) | active | Sept 2030 |
| Raksharab Vaccine Sterile suspension for Injection | 🇿🇲Zambia | Indian Immunologicals Limited (A wholly owned subsidiary of the NDDB) | active | Oct 2028 |
| CHIRORAB | 🇿🇦South Africa | KAHMA BIOTECH (Pty) Ltd | active | Jan 1900 |
| Raksharab Suspension for injection | 🇹🇿Tanzania | INDIAN IMMUNOLOGICAL LIMITED | active | — |
| NOBIVAC RABIES VACCINE Suspension for injection | 🇹🇿Tanzania | INTERVET SOUTH AFRICA (PTY) LTD | active | — |
| Verorab Powder | 🇹🇿Tanzania | Sanofi Pasteur | active | — |
| Nobivac® Rabies 10-Dose Suspension for injection | 🇹🇿Tanzania | INTERVET SOUTH AFRICA (PTY) LTD | active | — |
Rabies Virus in Africa — Regulatory Overview
Rabies Virus is registered across 3 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, Zambia, South Africa. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 7 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.